Market Tracker

01/30 6:05pm ET

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

30.43
Data as of Jan 30
 -0.62 / -2.00%
Today’s Change
15.64
Today|||52-Week Range
35.01
-4.16%
Year-to-Date

Today’s Trading

Previous close31.05
Today’s open30.88
Day’s range30.36 - 31.73
Volume1,130,092
Average volume (3 months)1,278,118
Market cap$3.1B
Dividend yield--
Data as of 4:00pm ET, 01/30/2015

Growth & Valuation

Earnings growth (last year)-15.79%
Earnings growth (this year)-107.79%
Earnings growth (next 5 years)--
Revenue growth (last year)-76.67%
P/E ratioNM
Price/Sales1,870.76
Price/Book15.53

Competitors

 Today’s
change
Today’s
% change
WXWuxi Pharmatech Caym...-0.61-1.50%
MYGNMyriad Genetics Inc-0.92-2.40%
IPXLImpax Laboratories I...-1.02-2.71%
RCPTReceptos Inc-2.54-2.25%
Data as of 4:14pm ET, 01/30/2015

Financials

Next reporting dateMarch 10, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$1.1M
Annual profit (last year)-$37.9M
Net profit margin-3,314.24%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Director &
CAO
Uli Hacksell
Executive VP, Chief Financial &
Business Officer
Stephen R. Davis
Corporate headquarters
San Diego, California

Forecasts